A report on the outcomes of 1211 men undergoing active surveillance, including 11 BRCA1, 11 BRCA2 and 5 ATM germline carriers, has shown that BRCA2 carriers are more likely to undergo a tumour grade re-classification in subsequent biopsies. The gene discussed is ATM; the disease is neoplasm.